Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,235 shares of the medical equipment provider’s stock after selling 1,098 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Intuitive Surgical were worth $21,902,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Gilbert & Cook Inc. boosted its holdings in Intuitive Surgical by 6.5% in the fourth quarter. Gilbert & Cook Inc. now owns 3,437 shares of the medical equipment provider’s stock valued at $1,160,000 after purchasing an additional 211 shares during the last quarter. TrinityPoint Wealth LLC lifted its holdings in shares of Intuitive Surgical by 21.5% in the 4th quarter. TrinityPoint Wealth LLC now owns 1,081 shares of the medical equipment provider’s stock valued at $365,000 after buying an additional 191 shares during the period. EverSource Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 7.8% in the fourth quarter. EverSource Wealth Advisors LLC now owns 854 shares of the medical equipment provider’s stock worth $288,000 after buying an additional 62 shares during the last quarter. Ontario Teachers Pension Plan Board raised its position in Intuitive Surgical by 3.7% during the fourth quarter. Ontario Teachers Pension Plan Board now owns 3,062 shares of the medical equipment provider’s stock valued at $1,033,000 after acquiring an additional 109 shares in the last quarter. Finally, US Bancorp DE lifted its holdings in Intuitive Surgical by 12.7% in the fourth quarter. US Bancorp DE now owns 69,919 shares of the medical equipment provider’s stock valued at $23,588,000 after acquiring an additional 7,880 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Myriam Curet sold 2,818 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $1,291,010.34. Following the completion of the sale, the executive vice president now directly owns 298 shares in the company, valued at $136,522.74. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,655,048.26. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 2,818 shares of Intuitive Surgical stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $1,291,010.34. Following the completion of the sale, the executive vice president now owns 298 shares in the company, valued at approximately $136,522.74. The disclosure for this sale can be found here. In the last quarter, insiders have sold 53,120 shares of company stock valued at $25,528,753. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ISRG has been the topic of a number of analyst reports. The Goldman Sachs Group started coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They set a “buy” rating and a $500.00 price objective on the stock. Truist Financial raised their price target on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Evercore ISI dropped their target price on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research report on Friday, July 19th. Finally, BTIG Research lifted their price target on Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $446.45.

Intuitive Surgical Price Performance

ISRG opened at $486.20 on Friday. The company’s 50 day simple moving average is $468.01 and its two-hundred day simple moving average is $424.86. The firm has a market capitalization of $172.46 billion, a price-to-earnings ratio of 87.76, a price-to-earnings-growth ratio of 5.41 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $496.18.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same quarter in the previous year, the company posted $1.18 earnings per share. The firm’s revenue for the quarter was up 14.5% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.